https://www.gsk.com/en-gb/media/press-releases/gsk-announces-daprodustat-phase-3-headline-results/
GSK announces positive headline results from five Phase 3 studies of daprodustat for patients with...
Full results to be presented at a medical meeting later this year
https://www.mayoclinic.org/drugs-supplements/daprodustat-oral-route/description/drg-20544727
Daprodustat (oral route) - Side effects & dosage - Mayo Clinic
oral routeside effectsdaprodustatdosagemayo
https://www.gsk.com/en-gb/media/press-releases/gsk-receives-positive-chmp-opinion/
GSK receives positive CHMP opinion recommending authorisation of daprodustat for symptomatic...
The positive CHMP opinion is based on data from three global phase III trials in dialysis patients from the ASCEND clinical trial programme.
gskreceivespositivechmpopinion
https://www.gsk.com/en-gb/media/press-releases/gsk-announces-update-on-us-fda-regulatory-review-of-daprodustat-in-anaemia-of-chronic-kidney-disease/
GSK announces update on US FDA regulatory review of daprodustat in anaemia of chronic kidney...
GSK today announced that the US FDA will convene a meeting of the Cardiovascular and Renal Drugs Advisory Committee to review daprodustat